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Abstract 
Background: Malaria is one of the most serious and widespread parasitic diseases affecting humans. Because of the 
spread of resistance in both parasites and the mosquito vectors to anti‑malarial drugs and insecticides, controlling the 
spread of malaria is becoming difficult. Thus, identifying new drug targets is urgently needed. Helicases play key roles 
in a wide range of cellular activities involving DNA and RNA transactions, making them attractive anti‑malarial drug 
targets.
Methods: ATP‑dependent DNA helicase gene (PfRuvB3) of Plasmodium falciparum strain K1, a chloroquine and 
pyrimethamine‑resistant strain, was inserted into pQE‑TriSystem His‑Strep 2 vector, heterologously expressed and 
affinity purified. Identity of recombinant PfRuvB3 was confirmed by western blotting coupled with tandem mass 
spectrometry. Helicase and ATPase activities were characterized as well as co‑factors required for optimal function.
Results: Recombinant PfRuvB3 has molecular size of 59 kDa, showing both DNA helicase and ATPase activities. Its 
helicase activity is dependent on divalent cations (Cu2+, Mg2+, Ni+2 or Zn+2) and ATP or dATP but is inhibited by high 
NaCl concentration (>100 mM). PfPuvB3 is unable to act on blunt‑ended duplex DNA, but manifests ATPase activity in 
the presence of either single‑ or double‑stranded DNA. PfRuvB3.is inhibited by doxorubicin, daunorubicin and netrop‑
sin, known DNA helicase inhibitors.
Conclusions: Purified recombinant PfRuvB3 contains both DNA helicase and ATPase activities. Differences in proper‑
ties of RuvB between the malaria parasite obtained from the study and human host provide an avenue leading to the 
development of novel drugs targeting specifically the malaria form of RuvB family of DNA helicases.
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Background
Malaria is one of the most serious and widespread 
parasitic diseases of humans. Globally, in 2015 an esti-
mated 3.2 billion people were at risk of being infected 
with malaria parasites and contracting the disease, with 
approximately 214 million people becoming infected 
resulting in a mortality of 438,000 [1]. With the emer-
gence of drug-resistant parasites to all available anti-
malarials, control of malaria is becoming difficult [1, 2]. 
This has led to efforts in developing novel strategies and 
in a search for new drug targets with which to combat the 
scourge of malaria.
The availability of the complete genome sequence of 
Plasmodium falciparum, the causative agent of fatal 
malaria, has opened new avenues to identify genes 
important for parasite survival. Many potential chemo-
therapeutic targets involved in various metabolic path-
ways at different malaria parasite life stages have been 
identified recently [3]. Among these, helicases constitute 
a highly conserved group of enzymes important in all 
aspects of nucleic acid metabolism, such as replication, 
recombination, repair, transcription and (RNA) stability 
[3–6].
RuvB is an ATP-dependent DNA helicase with a 
hexameric ring structure and its architecture has been 
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suggested to be related to those of members of ATPases 
associated with various cellular activities (AAA+) pro-
tein class [6]. In Escherichia coli, RuvAB helicase is an 
ATP-driven translocase that promotes branch migra-
tion of Holliday junction and formation of heteroduplex 
DNA [6], in addition to being essential for replication 
fork reversal at occurrences of DNA replication defects 
[7]. Expression of E. coli ruvB genes is required for DNA 
repair and maintaining normal levels of cellular resist-
ance to stress-induced mutagenesis, so their resulting 
mutants are thereby defective in recombination [8, 9]. 
In eukaryotes, RuvB proteins, such as yeast RvB1 and 
RvB2, are nuclear proteins indispensable for cell cycle 
progression and RNA polymerase II-dependent tran-
scription [10]. In addition, RuvBs are involved directly 
in the regulation of transcription of over 5% of yeast 
genes as essential components of a chromatin remodel-
ling complex determining genes regulated by the com-
plex [11] and indirectly by recruiting the TATA-binding 
protein (TBP) to the promoter and its impairment confer 
growth defects [12], and they are essential for viability in 
all model organisms including Saccharomyces cerevisiae 
[13], Drosophila melanogaster [14] and Caenorhabditis 
elegans [15]. Mutations in the conserved ATP-binding 
and hydrolysis motifs of RuvBs decrease viability of these 
organisms [11].
Given that RuvBs play essential roles in nearly all 
aspects of nucleic acid metabolism, P. falciparum RuvBs 
should be no exception. Analysis of P. falciparum genome 
database identifies at least three RuvB homologues, 
namely, PfRuvB1, PfRuvB2 and PfRuvB3 [16]. PfRuvB3, 
located on chromosome 13, comprises of 1452 bp encod-
ing for a 483-amino acid protein [17]. Recombinant 
PfRuvB1 and PfRuvB2 containing both helicase and 
ATPase activities, and have been heterologously pro-
duced in E. coli and their properties characterized [18, 
19]. However, recombinant PfRuvB3 shows only ATPase 
activity, unlike that of the purified parasite protein that 
contains both helicase and ATPase activities [19, 20]. It 
is possible that the reported conditions for cloning and 
expression were not optimal for producing fully active 
enzyme. Here, conditions for generating PfRuvB3 dual 
activity in E. coli were examined and the effects of a num-
ber of known helicase inhibitors on the recombinant 
enzyme were also evaluated.
Methods
Cloning of Plasmodium falciparum ATP‑dependent DNA 
helicase gene (PfRuvB3)
Full length PfRuvB3 from P. falciparum K1, a chlo-
roquine and pyrimethamine-resistant strain from 
Thailand [21], was PCR amplified using primers 
5 ′-TCCCCCGGGGCATGAAGCTCGAAGAAG-3 ′ 
(with a SmaI site (underlined) upstream of the start 
codon) and 5′-CCGCTCGAGATTACTTGTACTTGA 
ATTTTCCG-3′ (with a XhoI site shown underlined) 
based on genome sequence of P. falciparum 3D7 (NCBI 
database accession no. XM001350297.1). Thermocycling 
conditions were as follows: 95 °C for 5 min; followed by 
35 cycles of 95 °C for 10 s, 61.5 °C for 30 s and 72 °C for 
1 min; with a final step at 72 °C for 90 s. The PCR was car-
ried out using Phusion® High-Fidelity DNA Polymerase 
(Thermo Scientific, MA, USA) and amplicon was puri-
fied using Nucleospin® extract II kit (Macherey-Magel, 
Düren, Germany), digested with SmaI and XhoI, and 
then ligated to similarly digested pQE-TriSystem His-
Strep 2 expression vector (Qiagen, Germany) using T4 
DNA ligase. The presence of PfRuvB3 in the recombinant 
plasmid was further verified for its nucleotide sequence 
by BioDesign (Pathumthani, Thailand).
Heterologous expression of PfRuvB3 and purification 
of recombinant protein
Recombinant pQE-TriSystem His-Strep 2-PfRuvB3 plas-
mid was transfected into Mix & Go Competent Cells-
Strain JM109 (Zymo Research Corporation, CA, USA) 
and transformed cells were selected on LB agar contain-
ing 100 μg/ml of ampicillin at 37  °C overnight. Cultures 
were inoculated into LB broth containing 100  μg/ml 
of ampicillin and grown at 37  °C until A600 nm reached 
0.4-0.6, and then treated with 1  mM isopropyl β-d-1-
thiogalactopyranoside (IPTG) at 37 °C for 1 h with shak-
ing. Cells were harvested by centrifugation at 2000×g at 
4  °C for 15  min, washed with buffer (50  mM NaH2PO4 
pH 8.0, 300 mM NaCl and 10 mM imidazole) and re-sus-
pended in buffer supplemented with protease inhibitor 
cocktail (complete™ ULTRA Tablets, Roche, Germany) 
before being lysed by sonication. Following centrifu-
gation at 9500×g at 4  °C for 45  min, supernatant was 
applied onto a Ni–NTA affinity column (Qiagen, Hilden, 
Germany), which was washed with washing buffer 
(50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imida-
zole and 1 mM PMSF) until no protein was detected in 
washed fractions. Recombinant PfRuvB3 was eluted with 
elution buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl 
and 250 mM imidazole) and fractions collected were sub-
jected to analysis SDS-PAGE. Fractions containing the 
6xHistidine-tag fusion protein were pooled and applied 
onto a 1  ml Strep-Tactin® Sepharose® column (Iba Life 
Sciences, Germany), which was washed with 5  ml of 
buffer A (100 mM Tris–HCl pH 8.0, 150 mM NaCl and 
1 mM EDTA) and recombinant PfRuvB3 was eluted with 
buffer A containing 2.5 mM desthiobiotin. The recombi-
nant protein was concentrated using an Amicon® Ultra-
15 filtration unit and stored in buffer B (50 mM NaH2PO4 
pH 8.0, 100  mM NaCl and 30% glycerol). Protein 
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concentration was measured using Bradford assay (Bio-
Rad, CA, USA) and protein purity was checked by 
SDS-PAGE.
Western blot and tandem mass spectrometry analysis
Following SDS-PAGE protein was transferred onto nitro-
cellulose membrane (Bio-Rad), which then was incubated 
with phosphate-buffered saline (PBS) containing 3% 
(w/v) bovine serum albumin (BSA) and 0.5% (v/v) Tween 
20 for 1 h at room temperature, washed three times with 
PBS buffer containing 0.1% (v/v) Tween 20 and incubated 
with Strep-Tactin® horse radish peroxidase conjugate 
(diluted 1:100 in PBS/BSA/Tween buffer) for 1 h at room 
temperature. After washing 2 times, protein was visual-
ized using SuperSignal™ West Pico Chemiluminescent 
Substrate (Thermo Scientific). Protein band stained with 
Coomassie blue dye was eluted from SDS–polyacryla-
mide gel, digested with trypsin and amino acid sequence 
of the peptides analyzed using Synapt HDMS Q-TOF 
LC–MS/MS equipped with MASCOT software (Waters, 
UK).
Preparation of DNA helicase substrates
DNA helicase substrates (Table 1) were prepared as fol-
lows. Oligodeoxynucleotides were 5′-end labelled using 
T4 polynucleotide kinase and [γ-32P] ATP (800 Cim-
Mol−1; PerkinElmer, MA, USA). Partial duplex of either 
short or long oligonucleotide was produced by anneal-
ing 34  μM [32P]-labelled oligodeoxynucleotide type 1 
or 4 (Table 1) to single-stranded circular M13mp18 (+) 
DNA (New England Biolabs, MA, USA) in 20 mM Tris–
HCl pH 7.5 containing 10  mM MgCl2, 100  mM NaCl 
and 1 mM DTT, incubating at 95 °C for 5 min and then 
cooling down slowly to room temperature over a period 
of 1 h [22]. Blunt ended DNA duplex was constructed by 
annealing 5  ng of 5′ end [32P]-labelled oligonucleotide 
type 5–50  ng of oligodeoxynucleotide type 6 in 40  mM 
Tris–HCl pH 7.5 containing 20 mM MgCl2, and 50 mM 
NaCl at 95 °C for 5 min and then cooling to room tem-
perature as described above. Fork-like substrates with 3′, 
5′ or both 3′ and 5′ overhanging ends were generated by 
annealing single-stranded circular M13mp18 (+) DNA 
with 5′ end [32P]-labelled oligodeoxynucleotide type 2, 3 
and 7, respectively.
DNA helicase activity assay
Unwinding of [32P]-labelled partial duplex DNA was 
employed as a measurement of helicase activity. The reac-
tion mixture (10 µl) contained 20 mM Tris–HCl pH 9.0, 
8 mM DTT, 2 mM MgCl2, 2 mM ATP, 10 mM KCl, 4% 
(w/v) sucrose, 80 mg/ml BSA, [32P]-labelled DNA duplex 
substrate (Table 1) and purified PfRuvB3. The assay was 
performed at 37  °C for 90  min (unless indicated other-
wise) and terminated with addition of 10X DNA loading 
dye (Fermentas, USA) and further incubation at 37 °C for 
5 min. Helicase substrate and product were separated by 
12% non-denaturing PAGE and then the gel was exposed 
to an X-ray film. DNA unwinding was quantified by den-
sitometric analysis of exposed substrate and product 
bands using GeneTools (Syngene). Percent unwinding 
is calculated using the following formula: [band density 
of product [single-stranded (ss)DNA] /  (band density of 
ssDNA + band density of substrate (duplex DNA)] × 100 
minus [percent unwinding in the absence of enzyme].
Requirement of co‑factors and effects of other factors
The ability of PfRuvB3 to hydrolyze different NTPs was 
studied by including 2 mM dATP, dCTP, dGTP, or dTTP 
in place of ATP in the standard reaction assay. The effects 
of ATP concentrations ranging from 0.3 to 20  mM on 
helicase activity were also determined. Divalent cation 
requirement was investigated mixture 2  mM CaCl2, 
CuCl2, NiSO4, ZnCl2, FeSO4, MnCl2 or MgSO4 in place of 
MgCl2. Effects of salt (0-200 mM NaCl in place of 10 mM 
KCl) and EDTA (5 mM) also were evaluated.
Effect of DNA helicase inhibitors on PfRuvB3 activity
Known DNA helicase inhibitors, aphidicolin genistein, 
daunorubicin, doxorubicin, mitoxantrone, and netropsin 
(Sigma, USA) were prepared as 10−2 M stock solutions 
in dimethylsulfoxide (DMSO) and stored at −20 °C until 
used. All compounds were diluted with 10 mM Tris–HCl, 
Table 1 Oligonucleotides and DNA duplex substrates used 
in the study






5. 41mer‑I 5′‑AATTCGAGCTCGGTACCCGGGGATCCTCTAGA 
GTCGACCTG‑3′
6. 41mer‑II 5′‑CAGGTCGACTCTAGAGGATCCCCGGGTACCG 
AGCTCGAATT‑3′
7. 47mer 5′‑TTTTTTTTTTTTTTTGTTTTCCCAGTCACGA 
CTTTTTTTTTTTTTTT‑3′
DNA duplex Component
Short oligonucleotide M13mp18 + 17mer
Long oligonucleotide M13mp18 + 34 mer
Blunted end 41 mer‑I + 41 mer‑II
3′overhang M13mp18 + 32 mer‑II
5′overhang M13mp18 + 32 mer‑I
3′and 5′ overhang M13mp18 + 47 mer
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pH 9.0 to specified concentrations for the assay. M13-17-
mer duplex DNA was pre-incubated with 0.1 to 50  μM 
drug for 10  min prior to addition to the standard heli-
case assay mixture. The 0.5% (v/v final concentration) 
of DMSO was used as solvent control to determine its 
effects on helicase activity. The dose–response curves of 
relative activities of PfRuvB3 and various drug concen-
trations were generated, and half-maximal inhibitory 
concentration (IC50), the concentration of compound 
to inhibit enzyme activity by 50%, was obtained using 
GraphPad Prism 6.01 software.
PfRuvB3 ATPase activity assay
ATPase reaction mixture (10  μl), containing reaction 
buffer (20  mM Tris–HCl pH 8.0, 8  mM DTT, 2  mM 
MgCl2, 10  mM KCl, 4% (w/v) sucrose and 80  mg/ml 
BSA), 1 μg of recombinant PfRuvB3, 50 ng of M13 mp18 
(New England Biolabs, USA) or short oligonucleotide 
duplex (Table  1), 1  mM ATP and 85  nM [α-32P] ATP 
(Perkin and Elmer, USA), was incubated at 37  °C for 
90  min. The reaction was terminated by the addition 
of 2  µl of 100  mM EDTA. One µl aliquot of the reac-
tion mixture was spotted onto a PEI cellulose thin layer 
chromatography plate (Sigma), which was developed in 
2 M acetic acid containing 1.5 M LiCl2 to separate ADP 
and ATP. Plate was dried and exposed to X-ray film and 
exposed bands quantified by densitometry as described 
above. Percent of [α-32P] ATP hydrolyzed is calculated 
using the formula: (band density of ADP/band density of 
ADP + band density of ATP) ×100 minus (percent ATP 
hydrolyzed in the absence of enzyme). Effective helicase 
inhibitors were investigated for their inhibitory effects on 
PfRuvB3 ATPase activity.
Results
Production and purification of recombinant PfRuvB3
Specific primers corresponding to ATP-dependent DNA 
helicase gene sequence of P. falciparum strain 3D7 were 
used to amplify a 1456-bp fragment from chloroquine 
and pyrimethamine-resistant P. falciparum K1 strain. 
A His-Strep-tagged PfRuvB3 protein with a molecular 
weight of 59 kDa was heterologously produced and affin-
ity purified (Fig.  1a). Western blot analysis using Strep-
Tactin® conjugate detected the expected PfRuvB3 band 
(Fig.  1b). Based on amino acid sequence analysis, all 13 
peptides obtained from mass spectrometry were matched 
with the sequence of P. falciparum 3D7 PfRuvB3 with 
ion scores of 4512, indicating an extensive homology (p 
value <0.05).
PfRuvB3 DNA helicase activity
A series of double stranded DNA substrates were pre-
pared (Table  1) to examine the properties of PfRuvB3 
helicase activity. PfRuvB3 was able to unwind short (17 
mer), long (34 mer) and fork-like (32 and 47 mer) oligo-
nucleotides present in duplex DNA with the same rela-
tive activity, but not blunt-ended duplex DNA (Fig. 2c).
PfRuvB3 displayed time- and ATP concentration-
dependent DNA helicase activity using the short oligo-
nucleotide DNA duplex substrate (Figs.  3 and 4a). The 
ATP is required for the unwinding activity and increasing 
activity can still be observed up to 20 mM ATP (Fig. 4a). 
Of other dNTPs (dATP, dCTP, dGTP, and dTTP) tested, 
only dATP supported DNA unwinding activity of 
PfRuvB3 with similar activity as ATP (Table 2).
RuvB requires the presence of divalent cations as a 
cofactor for ATP hydrolysis. Mg2+ was necessary for 
PfRuvB3 unwinding activity and could be replaced with 
Cu2+, Ni2+, Co2+ and Zn2+, but not with Ca2+, Fe2+ or 
Mn2+ (Table  2). The absolute requirement of PfRuvB3 
helicase activity for divalent cations was further con-
firmed by addition of the metal chelator EDTA (5 mM) 
into the reaction mixture, which resulted in complete 
loss of helicase function.
The unwinding activity of PfRuvB3 was inhibited with 
increase in NaCl concentration and was almost absent in 
the presence of 100 mM of NaCl (Fig. 4b).
PfRuvB3 ATPase activity assay
The ability of the enzyme to hydrolyze ATP was tested. 
Recombinant PfRuvB3 revealed a time-dependent 
ATPase activity in the presence of Mg2+ when either sin-
gle- or double-stranded DNA was added to the reaction 
mixture (Fig. 5).
Fig. 1 SDS‑PAGE (a) and western blot (b) of purified PfRuvB3. Condi‑
tions for enzyme expression and purification are described under 
“Heterologous expression of PfRuvB3 and purification of recombinant 
protein”. The purified PfRuvB3 was analyzed by electrophoresis on a 
12% SDS gel. Western blotting was performed using Strep‑Tactin® 
horse radish peroxidase conjugate. Lane 1, molecular weight markers 
(kDa); lane 2, purified recombinant PfRuvB3
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Effect of DNA helicase inhibitors on PfRuvB3 activity
Known DNA helicase inhibitors such as daunorubicin 
and doxorubicin, DNA intercalators and netropsin, a 
minor groove binder were potent inhibitors of PfRuvB3 
helicase activity with IC50 value of 0.76, 2.6 and 7.09 μM, 
respectively (Fig. 6), but not aphidicolin, a DNA polymer-
ase inhibitor; genistein, a tyrosine kinase inhibitor and 
mitoxantrone, a DNA intercalator (IC50 value >50  μM). 
However, three effective helicase inhibitors showed very 
low inhibition on PfRuvB3 ATPase activity at a concen-
tration of 50 μM (Fig. 7).
Discussion
RuvBs are highly conserved ATP-binding proteins that 
belong to the AAA+  family of ATPases that are present 
in many organisms and are implicated in many cellular 
pathways [13, 14, 23–25]. In the P. falciparum genome, 
three P. falciparum proteins have been annotated as 
putative RuvB proteins. Phylogenetic comparison of the 
three PfRuvB protein sequences with those of E. coli, 
yeast and humans reveals that PfRuvB1 and PfRuvB2 are 
closer to human/yeast RuvBL1, but PfRuvB3 appears to 
be a homolog of human/yeast RuvBL2 [19].
Fig. 2 Substrate preference of recombinant PfRuvB3. Substrate preparation and assay conditions were as described under “Preparation of DNA 
helicase substrates” and “DNA helicase activity assay”. Helicase assays were carried out by using 1 μg of purified PfRuvB3 at 37 °C 90 min. Each panel 
shows substrate used and autoradiogram on gel. DNA duplex substrates in panels a, b, c, d, e and f were short oligonucleotide, long oligonucleo‑
tide, blunted end, 5′ overhang, 3′ overhang and 3′, 5′ overhang, respectively. Pentagon denotes 32P‑labelled end. Percent unwinding is shown 
above each autoradiogram. Lanes C and H are control reaction without enzyme and heat‑denatured substrate respectively. Lane E is reaction with 
recombinant PfRuvB3
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A previous study [20] reported that PfRuvB3 isolated 
directly from the parasite organism displayed both DNA 
helicase and ATPase and activities, but the recombinant 
protein is able only to recapitulate the ATPase activity 
[20]. Because the recombinant protein in the previous 
study originated from resolubilized bacteria-expressed 
inclusion bodies, it is possible that the refolded PfRuvB3 
lost the requisite motif(s) to unwind DNA duplexes.
With that in mind, full-length PfRuvB3 of P. falcipa-
rum K1 strain was cloned using pQE-TriSystem His-
Strep 2 Vector expression vector whereby the Strep-tag 
sequence (for identification in western blotting) is fused 
to PfRuvB3  N-terminus and the 8x His-tag sequence 
(for affinity purification) is located at the C-terminus, so 
as to minimize misfolding of the resulting recombinant 
protein. DNA sequencing revealed that RuvB3 of P. fal-
ciparum K1 strain is 100% identical to that of strain 3D7 
(NCBI database accession no. XM001350297.1). This 
putative PfRuvB3 (54  kDa) was confirmed by western 
blot and mass spectral analysis.
Purified heterologously expressed soluble recombinant 
PfRuvB3 has ATP-dependent DNA helicase without the 
need for any protein partner, a property similar to that 
of human RuvBL2 [26]. However, PfRuvB2/PfRuvB3 
complex exhibits a higher helicase activity than PfRuvB2 
alone [19]. Electron microscopic images of yeast Rvb1/
Rvb2 complex showed conformational changes after 
exposure to nucleotide [27–29] and this complex has 
stronger DNA helicase activity than the individual pro-
teins [28]. On the other hand, human RuvBL1/RuvBL2 
complex has ATPase activity but lacks helicase function 
[27]. It is possible that in a complex form the enzyme(s) 
may require additional cofactors for appreciable helicase 
activity or that to become fully active the enzyme com-
plex needs to establish a tight-binding ATP pocket. Thus, 
whether a DNA helicase functions better alone or as a 
complex depends on the species of interest.
Recombinant PfRuvB3 unwinds DNA duplexes con-
taining short (17-mer), long (34-mer) and fork-like (32 
and 47-mer) oligonucleotides similar to Mycoplasma 
pneumoniae RuvB homolog [30]. That PfRuvB3 is unable 
Fig. 3 Time‑dependent unwinding activity of recombinant PfRuvB3. 
Effects of incubation time on helicase activity of PfRuvB3 were 
determined using short oligonucleotide DNA duplex (Table 1) as a 
template. Assay conditions were as described under “DNA helicase 
activity assay”. Helicase assays were performed by using 1 μg of 
purified PfRuvB3 at 37 °C under various incubation periods as speci‑
fied in the figure. a Autoradiogram. b Kinetics of unwinding activity 
of recombinant PfRuvB3. Result is shown as mean ± SD of three 
replicates Fig. 4 Effects of ATP (a) and NaCl (b) on unwinding activity of 
recombinant PfRuvB3. Their effects were investigated using short 
oligonucleotide DNA duplex (Table 1) as a template. Assay condi‑
tions were as described under “DNA helicase activity assay”. Panel 
shows autoradiogram. Lanes C and H are control reaction without 
enzyme and heat‑denatured substrate respectively. Result is shown 
as mean ± SD of three replicates
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to handle blunt-ended duplex DNA substrate indicates 
that the enzyme requires a stretch of single-stranded 
DNA for initial binding, a property similar to that of E. 
coli RuvA [31].
Recombinant PfRuvB3 is dependent on the presence 
of divalent cations and ATP as found in other organisms 
[25–27, 30, 31]. High concentrations of divalent cations 
and salt were suggested to alter protein conformation or 
to interact directly to negatively charged groups of the 
enzyme, resulting in decreased enzyme activity [32, 33]. 
Approximately, 98% of enzyme activity was inhibited 
by NaCl at concentration of 200 mM (Table 2) which is 
higher than 154 mM of the physiological concentration. 
Interestingly, optimal PfRuvB3 helicase activity is able of 
utilizing dATP (but not the other three dNTPs), a fea-
ture it shares in common with that of E. coli, M. pneu-
monia, yeast and human homologs [30, 34, 35], although 
bacterial homologs show a relatively low level response 
in the presence of dCTP [35, 36]. These results suggest 
that ATP and dATP may promote stable formation of the 
conformation required for interaction between NTP and 
DNA binding domain of PfRuvB3. Similar to homologs in 
E. coli, Mycoplasma pneumonia, Mycoplasma genitalium, 
yeast and humans [25, 27, 36–38], recombinant PfRuvB3 
manifests ATPase activity in the presence of single- and 
double-stranded DNA.
Recombinant PfRuvB3 helicase activity was sus-
ceptible to inhibition by some DNA intercalators 
(daunorubicin and doxorubicin) but not to others 
(genistein and mitoxantrone), to DNA minor groove 
binder netropsin and not to non-intercalating topoi-
somerase inhibitor aphidicolin. None of these six 
compounds affected PfRuvB ATPase activity. All the 
effective inhibitors bind strongly to DNA [39], and so 
they most likely interfere with PfRuvB3 unwinding 
function, whose domain ought to be distant from that 
of ATPase. PfRuvB3 is more sensitive to daunorubicin 
(IC50 of 0.76 μM) than other helicases, such as P. falci-
parum DNA helicase A (PfDH A) [22], P. falciparum 
UvrD helicase (PfUDN) [40], P. falciparum 45 kDa heli-
case (PfH45) [41], P. falciparum 60  kDa DNA helicase 
(PfDH60) [42] and human DNA helicase (HDH II) [43] 
(IC50s of 2.0, 4.4, 5.0 3.0, 6.23  μM, respectively). How-
ever, it is less sensitive to netropsin (IC50 of 7.09  μM) 
than PfUDN, PfH45, PfDH60 and P. falciparum Dbp5/
DDX19 homolog (PfD66) [44] (IC50s of 3.3, 0.8, 0.5, 
3.2 μM, respectively). Inhibition of PfRuvB3 activity by 
Table 2 Requirement conditions of  PfRuvB3 unwinding 
activity
a 20 mM Tris–HCl (pH 9.0), 8 mM DTT, 2 mM MgCl2, 2 mM ATP, 10 mM KCl, 4% 








dNTP −ATP + dATPb 33
−ATP + dCTP <2
−ATP + dTTP <2
−ATP + dGTP <2
Divalent cation −MgCl2 + CaCl2c <2
−MgCl2 + CuCl2 36
−MgCl2 + NiCl2 34
−MgCl2 + ZnCl2 30
−MgCl2 + FeSO4 <2
−MgCl2 + MnCl2 <2
−MgCl2 + MgSO4 37
Salt +NaCl (200 mM) <2
+EDTA (5 mM) <2
Fig. 5 Time‑dependent ATPase activity of recombinant PfRuvB3. 
ATPase activity of PfRuvB3 were assayed using single‑stranded DNA 
(ssM13 mp18) under conditions as described in “PfRuvB3 ATPase 
activity assay”. ATPase assay was carried out at 37 °C under various 
incubation time ranging from 10 to 180 min. Control is ATPase assay 
without enzyme at 37 °C 180 min. a Autoradiogram. b Kinet‑
ics of ATPase activity of recombinant PfRuvB3. Result is shown as 
mean ± SD of three replicates
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daunorubicin (IC50 of 0.76  μM) and doxorubicin (IC50 
of 2.6 μM) did not correlate with parasite growth inhibi-
tion (IC50s of 2.5 and 1.5 μM respectively) [22] suggest-
ing that they may have different cell permeability and 
metabolic properties.
Conclusions
The availability of heterologously expressed soluble 
recombinant PfRuvB3 has permitted characterization of 
both its helicase and ATPase properties. Given the dif-
ferences between malaria parasite and host RuvB in size, 
amino acid sequence and sensitivity to known helicase 
inhibitors, such as daunorubicin, recombinant PfRuvB3 
may provide an opportunity for further design of novel 
and more specific inhibitors in the future.
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